Table 2 Characteristics of patients who have relapsed
Age | Sex | Stage | mid/pre tx MTV | mid/pre tx iSUV | Chemo | Clinical outcome | Survival |
|---|---|---|---|---|---|---|---|
17 | M | III A | 0 | 0 | Stanford V | Progressed at completion of chemo and RT | Alive |
12 | F | IV B | 6 | 7 | Stanford V | Progressed at completion of chemo and RT | Dead |
75 | M | IV B | 141 | 172 | ABVD | Dyspnea & fluid overload after cycle 4 of ABVD, h/o orthotopic heart transplant | Dead |
40 | M | III A | 74 | 33 | ABVD | Expanding large axillary mass, chemo suspended for surgical excision | Dead |
56 | M | IV B | 7 | 9 | BEACOPP | Died unexpectedly after 2 cycles chemo | Dead |
26 | M | III A | 0 | 0 | ABVD | Evidence of disease recurrence on PET-CT but asymptomatic | Alive |